You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Details for Patent: RE29835


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE29835
Title: 1,2,4-Triazole nucleosides
Abstract:As antiviral agents and intermediates therefor, 3-substituted 1-(.beta.-D-glycosyl)-1,2,4-triazoles, O-acylated analogs thereof, and 5'- and 3',5'-cyclic phosphates of the triazole nucleosides, "glycosyl" being .[.a pentofuranosyl moiety, preferably one whose 2'-oxygen is trans to the triazole aglycon, e.g., xylofuranosyl,.]. ribofuranosyl, .[.2-0-methylribofuranosyl, etc.,.]. the triazole aglycon being 3-substituted with cyano, methylcarboxylate, carboxamidoxime, carboxamido-, thiocarboxamido, or carboxamidine. Preparation of these nucleosides is by silylation of the substituted triazole followed by glycosylation with the appropriate blocked glycosyl halide. Alternatively, acid-catalyzed fusion of the requisite 1,2,4-triazole with an O-acylated pentofuranose yields the nucleosides.
Inventor(s): Witkowski; Joseph T. (Laguna Niguel, CA), Robins; Roland K. (Santa Ana, CA)
Assignee: ICN Pharmaceuticals (Irvine, CA)
Application Number:05/782,294
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex world of U.S. patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article delves into the intricacies of patent scope, claim drafting, and the broader patent landscape, using relevant examples and case studies to illustrate key points.

The Importance of Patent Scope

Defining Patent Scope

Patent scope refers to the breadth and depth of protection afforded by a patent. It is determined by the language of the patent claims, which must be carefully crafted to balance protection with the risk of invalidation[5].

Metrics for Measuring Patent Scope

Researchers have developed simple metrics to measure patent scope, such as independent claim length and independent claim count. These metrics have been validated by showing their explanatory power for various correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Crafting Effective Patent Claims

The Balance Between Breadth and Specificity

A common misconception is that broader claims are always better. However, overly broad claims are more difficult to get granted and easier to invalidate. Claims must be anchored to the embodiments disclosed in the specification to avoid running afoul of the abstract idea exception or failing to meet the written description requirement[5].

Avoiding the Abstract Idea Exception

The Supreme Court's decision in Alice v. CLS Bank introduced a framework for determining whether a claimed invention is directed to an abstract idea. Claims that generalize too far and invoke generic processes rather than specific means or methods risk being deemed patent-ineligible[5].

Case Study: Yu v. Apple Inc.

In Yu v. Apple Inc., the Federal Circuit court found that a claim was directed to an abstract idea because it described a result or effect rather than a specific means or method. This case highlights the importance of ensuring that claims are specific and improve the relevant technology[5].

Continuation Procedures and Their Impact on Patent Scope

Types of Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs), Continued Prosecution Applications (CPAs), and divisional applications, allow applicants to refine their claims and respond to examiner feedback. These procedures can significantly impact the scope of the patent by allowing for the introduction of new subject matter or the separation of distinct inventions[1].

Serialized vs. Non-Serialized Continuations

Serialized continuations, such as divisional applications, can result in multiple patents from a single progenitor application, each with the same priority date. Non-serialized continuations, like RCEs, are used after specific events in prosecution and do not receive a new serial number. These distinctions are crucial for understanding the potential scope and complexity of a patent family[1].

The Role of Inventorship in Patent Applications

Determining True Inventorship

U.S. patent law requires that the true inventors of patentable subject matter be listed on the patent application. Errors in inventorship can be corrected, but deceptive intent in naming inventors can render the patent unenforceable. The case of Frank’s Casing Crew v. PMR Technologies illustrates the severe consequences of fraudulent inventorship[4].

Patent Allowance Rates and Examination Process

Measures of Patent Allowance Rates

The probability of receiving a U.S. patent can be estimated through various measures, including first-action allowance rates, progenitor allowance rates, and family allowance rates. These metrics provide insights into the complexity of the examination process and the likelihood of a patent being granted[1].

Impact of Application Characteristics

The origin of the application (U.S. or foreign), the size of the entity filing (large or small), and the technology field can all influence the allowance rate. For instance, applications from small entities or in certain technology fields may have different success rates compared to others[1].

Court Decisions and Patent Validity

DDR Holdings, LLC v. NLG

In DDR Holdings, LLC v. NLG, the Federal Circuit upheld the validity of patents related to a system for generating composite web pages. The case involved challenges to the patents under 35 U.S.C. § 101 and § 112, highlighting the importance of clear and specific claim language in withstanding invalidation attempts[2].

Best Practices for Drafting Patent Claims

Anchoring Claims to the Specification

Claims must be grounded in the specific embodiments described in the patent specification. This ensures that the claims are not overly broad and are supported by the written description requirement[5].

Considering Prior Art and Technical Field

The level of prior art and the specific technical field can significantly impact the claim scope. In fields with extensive prior art, broader claims are more likely to be challenged and invalidated[5].

Balancing Claim Scope with Client Needs

The ideal claim scope depends on various factors, including the client’s budget, the level of prior art, and the specifics of the invention. Patent drafters must carefully balance these factors to ensure the success of the application and the strength of the granted patent[5].

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope.
  • Claim Specificity: Claims must be specific and anchored to the embodiments in the specification to avoid invalidation.
  • Continuation Procedures: These procedures can refine claims and impact the patent scope significantly.
  • Inventorship: True inventorship is crucial, and errors or deceptive intent can render a patent unenforceable.
  • Allowance Rates: Various measures can estimate the probability of patent allowance, influenced by application characteristics.
  • Court Decisions: Clear and specific claim language is essential for withstanding invalidation attempts.

FAQs

Q: What are the key metrics for measuring patent scope?

A: Independent claim length and independent claim count are commonly used metrics to measure patent scope[3].

Q: Why are overly broad claims risky?

A: Overly broad claims are more difficult to get granted and easier to invalidate due to the risk of falling under the abstract idea exception or failing to meet the written description requirement[5].

Q: What is the significance of continuation procedures in patent applications?

A: Continuation procedures allow applicants to refine their claims, introduce new subject matter, or separate distinct inventions, which can impact the patent scope and complexity[1].

Q: How important is accurate inventorship in patent applications?

A: Accurate inventorship is crucial; errors or deceptive intent can render the patent unenforceable[4].

Q: What factors influence the allowance rate of a patent application?

A: The origin of the application, the size of the entity filing, and the technology field can all influence the allowance rate[1].

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. DDR Holdings, LLC v. National Leisure Group, Inc., No. 13-1505 (Fed. Cir. Dec. 5, 2014). Retrieved from https://cafc.uscourts.gov/opinions-orders/13-1505.opinion.12-3-2014.1.pdf
  3. Patent Claims and Patent Scope. (2016, September 29). Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Determining Inventorship for US Patent Applications. Retrieved from https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  5. The Importance of Getting the Claim Scope Right in a US Patent Application. (2021, October 4). Retrieved from https://www.rimonlaw.com/the-importance-of-getting-the-claim-scope-right-in-a-us-patent-application-i/

More… ↓

⤷  Try for Free


Drugs Protected by US Patent RE29835

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent RE29835

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 199463 ⤷  Try for Free
Argentina 205339 ⤷  Try for Free
Argentina 207138 ⤷  Try for Free
Argentina 224992 ⤷  Try for Free
Austria 336199 ⤷  Try for Free
Austria A465772 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.